Ç÷Àü Á¦°Å µð¹ÙÀ̽º ½ÃÀå : Á¦Ç° À¯Çüº°, ¿ëµµº°, ÃÖÁ¾»ç¿ëÀÚº°, Áö¿ªº°
Thrombectomy Devices Market, By Product Type, By Application, By End User, By Geography
»óǰÄÚµå
:
1358053
¸®¼Ä¡»ç
:
Coherent Market Insights
¹ßÇàÀÏ
:
2023³â 09¿ù
ÆäÀÌÁö Á¤º¸
:
¿µ¹®
¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
¤± Add-on °¡´É: °í°´ÀÇ ¿äû¿¡ µû¶ó ÀÏÁ¤ÇÑ ¹üÀ§ ³»¿¡¼ CustomizationÀÌ °¡´ÉÇÕ´Ï´Ù. ÀÚ¼¼ÇÑ »çÇ×Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.
¼¼°èÀÇ Ç÷Àü Á¦°Å µð¹ÙÀ̽º ½ÃÀåÀº 2023³â¿¡ 16¾ï 8,000¸¸ ´Þ·¯·Î ÃßÁ¤µÇ¸ç, ¿¹Ãø ±â°£ Áß(2023-20301³â)¿¡ 7.5%ÀÇ CAGRÀ» º¸ÀÏ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.
¸®Æ÷Æ® ´ë»ó ¹üÀ§ |
¸®Æ÷Æ® »ó¼¼ |
±âÁسâ |
2022³â |
2023³â ½ÃÀå ±Ô¸ð |
16¾ï 8,000¸¸ ´Þ·¯ |
½ÇÀû µ¥ÀÌÅÍ |
2018-2021³â |
¿¹Ãø ±â°£ |
2023-2030 |
¿¹Ãø ±â°£ CAGR |
7.50% |
2030³â ½ÃÀå ±Ô¸ð ¿¹Ãø |
27¾ï 8,000¸¸ ´Þ·¯ |
¼¼°èÀÇ Ç÷Àü Á¦°Å µð¹ÙÀ̽º ½ÃÀå Á¡À¯À²(%), Á¦Ç° À¯Çüº°, 2023³â

Ç÷Àü Á¦°Å¼úÀº Ç÷°ü¿¡¼ ºÎµå·¯¿î Ç÷ÀüÀ» ¹°¸®ÀûÀ¸·Î Á¦°ÅÇÏ´Â °ÍÀ» ¸»ÇÕ´Ï´Ù. Ç÷Àü Á¦°Å Àåºñ´Â »ç¿ëÇϱ⠽±°í Áö¼ÓÀûÀ¸·Î Ç÷°üÀ» ¿¾î Ç÷ÀüÀ» Á¦°ÅÇÕ´Ï´Ù. Ç÷Àü Á¦°Å ÀåºñÀÇ »ç¿ëÀº ½Ã¼ú¿¡ ÀÇÇÑ Àç°ü·ùÀ²À» ³ô¿© ÇãÇ÷¼º ³ú ¼Õ»ó°ú °°Àº Àå±âÀûÀÎ ½Å°æÇÐÀû °á°ú¸¦ °³¼±ÇÒ ¼ö ÀÖ½À´Ï´Ù. Àç°ü·ù°¡ ½ÃÀ۵Ǹé Ç÷ÀüÀÌ ºÎµå·¯¿öÁö°í ºÎºÐÀûÀ¸·Î ¿ëÇØµÇ¾î ÀÓ»óÀû ȸº¹À» ³ªÅ¸³À´Ï´Ù. Ç÷Àü Á¦°Å Àåºñ´Â Ç÷Àü ¿ëÇØ ¿ä¹ý°ú °°Àº ¾à¹° ¿ä¹ýÀÌ È¿°ú°¡ ¾ø°Å³ª ºÎÀûÀýÇÑ È¯ÀÚ, ½ÉÇ÷°ü ¼ö¼úÀ» ¹ÞÀº ȯÀÚ, °æ±¸¿ë Ç×ÀÀ°íÁ¦¸¦ º¹¿ëÇϴ ȯÀÚ µî¿¡ »ç¿ëÇÒ ¼ö ÀÖ½À´Ï´Ù. ±â°è½Ä ÈíÀÔ Ç÷Àü Á¦°Å Àåºñ´Â ÀÌÁß ³»° Ä«Å×ÅͷΠǥÁØ 0.014ÀÎÄ¡ÀÇ °¡À̵å¿ÍÀ̾ »ç¿ëÇÏ¿© ¿øÀÎ º´º¯À» °¡·ÎÁö¸£¸ç, µÎ °³ÀÇ ³»° Áß ´õ ¾ãÀº ³»°ÀÌ °¡À̵å¿ÍÀ̾î·Î ±¸¼ºµÇ¾î ÀÖÀ¸¸ç, ºü¸¥ ±³È¯ ¸ð³ë·¹ÀÏ ½Ã½ºÅÛÀ» »ç¿ëÇÕ´Ï´Ù. ¸»ÃÊ Ç÷Àü Á¦°Å¼úÀº ¸»ÃÊ µ¿¸Æ Áúȯ(PAD), ±Þ¼º »çÁö ÇãÇ÷(ALI), ÁßÁõ »çÁö ÇãÇ÷(CLI), ¸¸¼º ¿ÏÀü Æó¼â(CTO), ½ÉºÎ Á¤¸Æ Ç÷ÀüÁõ(DVT), Æó»öÀüÁõ(PE) ¹× ±âŸ ¸»ÃÊ Ç÷°ü Áúȯ(PVD)°ú °ü·ÃÀÌ ÀÖ½À´Ï´Ù.
½ÃÀå ¿ªÇÐ
¹Ì±¹ ½ÄǰÀǾ౹(FDA)°ú °°Àº ±ÔÁ¦ ´ç±¹ÀÇ Á¦Ç° ½ÂÀÎ Áõ°¡´Â ¿¹Ãø ±â°£ Áß ¼¼°è Ç÷Àü Á¦°Å Àåºñ ½ÃÀåÀÇ ¼ºÀåÀ» °¡¼ÓÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ¿¹¸¦ µé¾î 2020³â 5¿ù ÀÇ·á ±â¼ú ±â¾÷ Control Medical Technology, LLC´Â ¹Ì±¹ ½ÄǰÀǾ౹(FDA)ÀÌ ¸»ÃÊ Ç÷°ü¿¡¼ Ç÷ÀüÀ» Á¦°ÅÇϵµ·Ï ¼³°èµÈ Aspire MAX 7-11F ±â°è½Ä Ç÷Àü Á¦°Å ½Ã½ºÅÛÀ» ½ÂÀÎÇß´Ù°í ¹ßÇ¥Çß½À´Ï´Ù. -11F ±â°è½Ä Ç÷Àü Á¦°Å ½Ã½ºÅÛ¿¡´Â Aspire Aspirator ¹×/¶Ç´Â Àü±â±â°è½Ä ÆßÇÁ¿¡ ÀÇÇØ ±¸µ¿µÇ´Â »õ·Î¿î Á÷°æÀÌ Å©°í À¯¿¬ÇÏ¸ç ²¿ÀÓ¿¡ °ÇÑ Ä«Å×ÅÍ(20°³)°¡ Æ÷ÇԵŠÀÖ½À´Ï´Ù.
º» Á¶»çÀÇ ÁÖ¿ä Æ¯Â¡
- ÀÌ Á¶»ç ¸®Æ÷Æ®´Â ¼¼°èÀÇ Ç÷Àü Á¦°Å µð¹ÙÀ̽º ½ÃÀåÀ» »ó¼¼ ºÐ¼®Çϰí, 2022³âÀ» ±âÁسâÀ¸·Î ÇÑ ¿¹Ãø ±â°£(2023-2030³â)ÀÇ ½ÃÀå ±Ô¸ð ¹× ¿¬Æò±Õ ¼ºÀå·ü(CAGR)À» Á¦°øÇÕ´Ï´Ù. ´Ù¾çÇÑ ºÎ¹®ÀÇ ÀáÀçÀû ¸ÅÃâ ±âȸ¸¦ ¼³¸íÇϰí, ÀÌ ½ÃÀåÀÇ ¸Å·ÂÀû ÅõÀÚ Á¦¾È ¸ÅÆ®¸¯½º¸¦ ÇØ¼³Çϰí ÀÖ½À´Ï´Ù.
- ½ÃÀå ÃËÁø¿äÀÎ, ¾ïÁ¦¿äÀÎ, ±âȸ, ½ÅÁ¦Ç° Ãâ½Ã ¹× ½ÂÀÎ, ½ÃÀå µ¿Çâ, Áö¿ªº° Àü¸Á, ÁÖ¿ä ±â¾÷ÀÌ Ã¤ÅÃÇÏ´Â °æÀï Àü·« µî¿¡ °üÇÑ ÁÖ¿ä ÀλçÀÌÆ®µµ Á¦°øÇϰí ÀÖ½À´Ï´Ù.
- ±â¾÷ ÇÏÀ̶óÀÌÆ®, Á¦Ç° Æ÷Æ®Æú¸®¿À, ÁÖ¿ä ÇÏÀ̶óÀÌÆ®, ½ÇÀû, Àü·« µîÀÇ ÆÄ¶ó¹ÌÅÍ¿¡ ±â¹ÝÇÏ¿© ¼¼°èÀÇ Ç÷Àü Á¦°Å µð¹ÙÀ̽º ½ÃÀåÀÇ ÁÖ¿ä ±â¾÷À» ÇÁ·ÎÆÄÀϸµÇϰí ÀÖ½À´Ï´Ù.
- ÀÌ ¸®Æ÷Æ®·ÎºÎÅÍÀÇ ÀλçÀÌÆ®´Â ¸¶ÄÉÆÃ ´ã´çÀÚ ¹× ±â¾÷ÀÇ °æ¿µÁøÀÌ ÇâÈÄ Á¦Ç° ¹ß¸Å, À¯Çü ¾÷±×·¹À̵å, ½ÃÀå È®´ë, ¸¶ÄÉÆÃ Àü¼ú¿¡ °üÇÑ Á¤º¸¿¡ ±â¹ÝÇÑ ÀÇ»ç°áÁ¤À» ½ÃÇàÇÏ´Â °ÍÀ» °¡´ÉÇÏ°Ô ÇÕ´Ï´Ù.
- ¼¼°èÀÇ Ç÷Àü Á¦°Å µð¹ÙÀ̽º ½ÃÀå ¸®Æ÷Æ®´Â ÅõÀÚÀÚ, °ø±Þ¾÷ü, Á¦Ç° Á¦Á¶¾÷ü, À¯Åë¾÷ü, ½Å±Ô Âü¿©¾÷ü, À繫 ¾Ö³Î¸®½ºÆ® µî ÀÌ ¾÷°èÀÇ ´Ù¾çÇÑ ÀÌÇØ°ü°èÀÚ¸¦ ´ë»óÀ¸·Î Çϰí ÀÖ½À´Ï´Ù.
- ÀÌÇØ°ü°èÀÚ´Â ¼¼°èÀÇ Ç÷Àü Á¦°Å µð¹ÙÀ̽º ½ÃÀå ºÐ¼®¿¡ »ç¿ëµÇ´Â ´Ù¾çÇÑ Àü·« ¸ÅÆ®¸¯½º¸¦ ÅëÇØ ÀÇ»ç°áÁ¤À» ¿ëÀÌÇÏ°Ô ÇÒ ¼ö ÀÖ½À´Ï´Ù.
¸ñÂ÷
Á¦1Àå Á¶»çÀÇ ¸ñÀû°ú ÀüÁ¦
Á¦2Àå ½ÃÀå Àü¸Á
- ¸®Æ÷Æ® ¼³¸í
- ÁÖ¿ä ¿ä¾à
- Coherent Opportunity Map(COM)
Á¦3Àå ½ÃÀå ¿ªÇÐ, ±ÔÁ¦, µ¿Ç⠺м®
- ½ÃÀå ¿ªÇÐ
- ÃËÁø¿äÀÎ
- ¾ïÁ¦¿äÀÎ
- ½ÃÀå ±âȸ
- ¿µÇ⠺м®
- ÃÖ±Ù Á¦Ç° ½ÂÀÎ/¹ß¸Å
- ÇÕº´, Àμö ¹× Çù¾÷
- ±ÔÁ¦ ½Ã³ª¸®¿À
- °¡°Ý ºÐ¼®
- ÁÖ¿ä ¹ßÀü
- PEST ºÐ¼®
- PorterÀÇ »ê¾÷ ºÐ¼®
Á¦4Àå ¼¼°èÀÇ Ç÷Àü Á¦°Å µð¹ÙÀ̽º ½ÃÀå - ½ÅÁ¾ Äڷγª¹ÙÀÌ·¯½º °¨¿°Áõ(COVID-19)ÀÇ ¿µÇ⠺м®
- °æÁ¦Àû ¿µÇâ
- ½ÅÁ¾ Äڷγª¹ÙÀÌ·¯½º °¨¿°Áõ(COVID-19) ¿ªÇÐ
- ¼ö¿ä¿Í °ø±Þ¿¡ ´ëÇÑ ¿µÇâ
Á¦5Àå ¼¼°èÀÇ Ç÷Àü Á¦°Å µð¹ÙÀ̽º ½ÃÀå : Á¦Ç° À¯Çüº°, 2018-2030³â
- ±â°èÀû Ç÷Àü Á¦°Å µð¹ÙÀ̽º
- ÈíÀÎ½Ä Ç÷Àü Á¦°Å µð¹ÙÀ̽º
- À¯Ã¼ ¿ªÇÐÀû Ç÷Àü Á¦°Å µð¹ÙÀ̽º
- ÃÊÀ½ÆÄ Ç÷Àü Á¦°Å µð¹ÙÀ̽º
Á¦6Àå ¼¼°èÀÇ Ç÷Àü Á¦°Å µð¹ÙÀ̽º ½ÃÀå : ¿ëµµº°, 2018-2030³â
- ½ÉºÎÁ¤¸ÆÇ÷ÀüÁõ(DVT)
- Æó»öÀüÁõ(PE)
- SVT(Superficial Vein Thrombosis)
- ½ÅÀå Á¤¸ÆÇ÷ÀüÁõ(RVT)
- µ¿¸ÆÇ÷Àü Áõ(¾ÆÅ×·Ò Ç÷ÀüÁõ)
- ±âŸ(ÇãÇ÷¼º ³úÁ¹Áß µî)
Á¦7Àå ¼¼°èÀÇ Ç÷Àü Á¦°Å µð¹ÙÀ̽º ½ÃÀå : ÃÖÁ¾»ç¿ëÀÚº°, 2018-2030³â
- º´¿ø
- ¿Ü·¡ ¼ö¼ú ¼¾ÅÍ
- ±âŸ(Çмú¿¬±¸±â°ü µî)
Á¦8Àå ¼¼°èÀÇ Ç÷Àü Á¦°Å µð¹ÙÀ̽º ½ÃÀå : Áö¿ªº°, 2018-2030³â
- ºÏ¹Ì
- ¹Ì±¹
- ij³ª´Ù
- À¯·´
- ¿µ±¹
- µ¶ÀÏ
- ÀÌÅ»¸®¾Æ
- ÇÁ¶û½º
- ½ºÆäÀÎ
- ·¯½Ã¾Æ
- ±âŸ À¯·´
- ¾Æ½Ã¾ÆÅÂÆò¾ç
- Áß±¹
- Àεµ
- ÀϺ»
- ASEAN
- È£ÁÖ
- Çѱ¹
- ±âŸ ¾Æ½Ã¾ÆÅÂÆò¾ç
- ¶óƾ¾Æ¸Þ¸®Ä«
- ºê¶óÁú
- ¸ß½ÃÄÚ
- ¾Æ¸£ÇîÆ¼³ª
- ±âŸ ¶óƾ¾Æ¸Þ¸®Ä«
- 秵- GCC
- À̽º¶ó¿¤
- ±âŸ Áßµ¿
- ¾ÆÇÁ¸®Ä«
- ºÏ¾ÆÇÁ¸®Ä«
- Áß¾Ó¾ÆÇÁ¸®Ä«
- ³²¾ÆÇÁ¸®Ä«
Á¦9Àå °æÀï ±¸µµ
- ±â¾÷ °³¿ä
- Boston Scientific Corporation
- Medtronic
- Merit Medical System Inc.
- Stryker Corporation
- Terumo Corporation
- Teleflex Incorporated
- Vetex Medical Ltd.
- Edwards Lifesciences Corporation
- Penumbra Inc.
- Control Medical Technology, LLC.
- Rapid Medical
- Abbott
- Surmodics Inc.
- Analysts'Views
Á¦10Àå ¼½¼Ç
KSA
¿µ¹® ¸ñÂ÷
Global thrombectomy devices market is estimated to be valued at US$ 1.68 Bn in 2023, and is expected to exhibit a CAGR of 7.5% during the forecast period (2023-2030).
Report Coverage |
Report Details |
Base Year: |
2022 |
Market Size in 2023: |
US$ 1.68 Bn |
Historical Data for: |
2018 to 2021 |
Forecast Period: |
2023 - 2030 |
Forecast Period 2023 to 2030 CAGR: |
7.50% |
2030 Value Projection: |
US$ 2.78 Bn |
Global Thrombectomy Devices Market Share (%), By Product Type, 2023

Thrombectomy refers to physical removal of soft thrombus from blood vessels. A thrombectomy device is easy to use, and it consistently opens blood vessels for the removal of blood clots. Use of thrombectomy devices can improve long-term neurological outcomes such as ischemic brain injury and others, by providing higher rates of procedural recanalization. Once recanalization starts, clot softens and partially dissolves, indicating clinical recovery. Thrombectomy devices can be used in patients, where pharmacological treatments such as thrombolysis are likely to be ineffective or inappropriate, in case of recent cardiovascular surgery or in patients taking oral anticoagulants. Mechanical aspiration thrombectomy devices are dual-lumen catheters that are passed across the culprit lesion over a standard 0.014-inch guidewire. Of the two lumens, the smaller lumen consists of the guidewire by using a rapid exchange monorail system. Peripheral thrombectomy is associated with peripheral arterial disease (PAD), acute limb ischemia (ALI), critical limb ischemia (CLI), chronic total occlusion (CTO), deep vein thrombosis (DVT), pulmonary embolism (PE), and other peripheral vascular disease (PVD).
Market Dynamics
Increasing product approvals by regulatory authorities such as U.S. Food and Drug Administration is expected to drive the global thrombectomy devices market growth over the forecast period. For instance, in May 2020, Control Medical Technology, LLC., a medical technology company, announced that the U.S. Food and Drug Administration had approved Aspire MAX 7 - 11F mechanical thrombectomy system that is designed to remove blood clots from the peripheral vessels. The Aspire MAX 7 - 11F mechanical thrombectomy system includes (20) new large-lumen, flexible, and kink-resistant catheters w/dilators powered by the Aspire Aspirator and/or an electromechanical pump.
Key features of the study:
- This report provides an in-depth analysis of the global thrombectomy devices market and provides market size (US$ Bn) and compound annual growth rate (CAGR) for the forecast period (2023-2030), considering 2022 as the base year It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
- It profiles key players in the global thrombectomy y devices market based on the following parameters- company highlights, products portfolio, key highlights, financial performance, and strategies.
- Key companies covered as a part of this study include Boston Scientific Corporation, Medtronic, Merit Medical System Inc., Stryker Corporation, Terumo Corporation, Teleflex Incorporated, Vetex Medical Ltd., Edwards Lifesciences Corporation, Penumbra Inc., Control Medical Technology, LLC., Rapid Medical, Abbott and Surmodics, Inc.
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
- Global thrombectomy devices market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global thrombectomy devices market
Thrombectomy Devices Market Detailed Segmentation:
- By Product Type:
- Mechanical Thrombectomy Devices
- Aspiration Thrombectomy Devices
- Hydrodynamic Thrombectomy Devices
- Ultrasonic Thrombectomy Devices
- By Application:
- Deep Vein Thrombosis (DVT)
- Pulmonary Embolism (PE)
- Superficial Vein Thrombosis
- Renal Vein Thrombosis (RVT)
- Arterial Thrombosis (Atherothrombosis)
- Others (Ischemic Stroke, etc.)
- By End User:
- Hospitals
- Ambulatory Surgical Centers
- Others (Academic and Research Institutes, etc)
- By Region:
- North America
- Latin America
- Europe
- Asia Pacific
- Middle East
- Africa
- Company Profiles
- Boston Scientific Corporation
- Medtronic
- Merit Medical System Inc.
- Stryker Corporation
- Terumo Corporation
- Teleflex Incorporated
- Vetex Medical Ltd.
- Edwards Lifesciences Corporation
- Penumbra Inc.
- Control Medical Technology, LLC.
- Rapid Medical
- Abbott
- Surmodics, Inc.
Table of Contents
1. Research Objective and Assumption
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snippet, By Product Type
- Market Snippet, By Application
- Market Snippet, By End User
- Market Snippet, By Region
- Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Restraints
- Market Opportunities
- Impact Analysis
- Recent Product Approvals/Launches
- Mergers, Acquisitions, and Collaborations
- Regulatory Scenario
- Pricing Analysis
- Key Developments
- PEST Analysis
- Porter's Analysis
4. Global Thrombectomy Devices Market - COVID-19 Impact Analysis
- Economic Impact
- COVID-19 Epidemiology
- Impact on Supply and Demand
5. Global Thrombectomy Devices Market, By Product Type, 2018- 2030, (US$ Bn)
- Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2018-2030
- Segment Trends
- Mechanical Thrombectomy Devices
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Bn)
- Segment Trends
- Aspiration Thrombectomy Devices
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Bn)
- Segment Trends
- Hydrodynamic Thrombectomy Devices
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Bn)
- Segment Trends
- Ultrasonic Thrombectomy Devices
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Bn)
- Segment Trends
6. Global Thrombectomy Devices Market, By Application, 2018 - 2030, (US$ Bn)
- Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2018-2030
- Segment Trends
- Deep Vein Thrombosis (DVT)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Bn)
- Segment Trends
- Pulmonary Embolism (PE)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Bn)
- Segment Trends
- Superficial Vein Thrombosis
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Bn)
- Segment Trends
- Renal Vein Thrombosis (RVT)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Bn)
- Segment Trends
- Arterial Thrombosis (Atherothrombosis)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Bn)
- Segment Trends
- Others (Ischemic Stroke, etc.)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Bn)
- Segment Trends
7. Global Thrombectomy Devices Market, By End User, 2018 - 2030, (US$ Bn)
- Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2018-2030
- Segment Trends
- Hospitals
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Bn)
- Ambulatory Surgical Centers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Bn)
- Others (Academic and Research Institutes, etc.)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Bn)
8. Global Thrombectomy Devices Market, By Region, 2018 - 2030, (US$ Bn)
- Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2018-2030
- Segment Trends
- North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2018 -2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2018 -2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2018 -2030, (US$ Bn)
- U.S.
- Canada
- Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2018 -2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2018 -2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2018 -2030, (US$ Bn)
- U.K.
- Germany
- Italy
- France
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth. By Product Type, 2018 -2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2018 -2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2018 -2030, (US$ Bn)
- China
- India
- Japan
- ASEAN
- Australia
- South Korea
- Rest of Asia Pacific
- Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2018 -2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2018 -2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth. By End User, 2018-2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2018 -2030, (US$ Bn)
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth By Product Type, 2018 -2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth By Application, 2018 -2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth By End User, 2018-2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth By Country, 2018 -2030, (US$ Bn)
- GCC
- Israel
- Rest of Middle East
- Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2018 -2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2018 -2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2018 -2030, (US$ Bn)
- North Africa
- Central Africa
- South Africa
9. Competitive Landscape
- Company Profiles
- Boston Scientific Corporation
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Overview
- Strategies
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Overview
- Strategies
- Merit Medical System Inc.
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Overview
- Strategies
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Overview
- Strategies
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Overview
- Strategies
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Overview
- Strategies
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Overview
- Strategies
- Edwards Lifesciences Corporation
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Overview
- Strategies
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Overview
- Strategies
- Control Medical Technology, LLC.
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Overview
- Strategies
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Overview
- Strategies
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Overview
- Strategies
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Overview
- Strategies
10. Section
- References
- Research Methodology
- About us and Sales Contact
°ü·ÃÀÚ·á